JAZZ - Europe's High: Irish GPs Against Pot Switzerland-Spain Share Data On Cannabis Clubs & More | Benzinga
Denmark: Medical Marijuana Pilot Program Experience 90% Growth In 12 Months
The number of patients enrolled in Denmark’s medical cannabis pilot trial grew more than 90% in 12 months, writes Business of Cannabis.
According to the report from the Danish Health Data Authority, the number of patients involved in the medical marijuana Pilot Programme, which commenced in 2018, hit record numbers in 2023. Now, it makes for the biggest access scheme in the country.
With medical marijuana not being completely regulated in Denmark there are various access schemes, such as:
-
Magistral Scheme – under which patients can access only products with CBD and THC isolates, so do not contain the cannabinoids present in full spectrum oils;
-
Pilot Programme - allows all doctors to prescribe any of the unlicensed medicines that have been approved for trial for any condition;
-
Pharmaceutical Scheme, which only allows Jazz Pharmaceuticals' (NASDAQ: JAZZ) Sativex and Epidoloex.
The popularity rise of the Pilot scheme could be attributed to several reasons among which are: the ability for any doctor to prescribe, the products based on the full spectrum cannabis plant, said Thomas Skovlund Schnegelsberg, CEO of Danish medical cannabis operator Stenocare.
"This means you don’t get the entourage effect that, according to the doctors that I’ve talked to… say they see a higher efficacy with the full spectrum, with all the cannabinoids,” Schnegelsberg said. He also added that the number revealed a preference shift to oils from flower.
Malta: Government Employee-Led Cannabis Club Breaks Advertising Rules
One of the first provisionally licensed "cannabis clubs” in Malta, Sprawt Chra, seems to have violated ...